Clinical trial · Interventional
Complete Decongestive Therapy on Head and Neck Lymphedema
The Effects of Complete Decongestive Therapy on Head and Neck Lymphedema in Post-surgical Head and Neck Cancer Patients (Randomized Control Trial)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This will be a prospective, randomized controlled study of \~60 adult patients who have undergone a laryngectomy, neck dissection, maxillectomy or mandibulectomy surgical procedure for the treatment of head and neck cancer at Our Lady of the Lake Hospital and have been referred by their physician for evaluation of head and neck lymphedema while serving as an inpatient. Consenting patients will be evaluated by certified speech and language pathologists trained to ascertain lymphedema severity using a series of visual and tangible measurements immediately following surgery and randomized into two cohorts, one receiving the complete decongestive therapy regimen and the other not receiving this specific combination treatment for their edema. Facial and neck measurements will be taken at baseline following surgery and at several points prior to and at discharge as well as at the 2 week follow up visit to the clinic. Measurements and overall change/reduction in edema will be compared between the cohorts.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphedema of Face | — | UNRESOLVED | — |
| Secondary Lymphedema | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Complete Decongestive Therapy | Procedure | — | UNRESOLVED |
| Observation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- CDT for head and neck lymphedema
- description
- Complete Decongestive Therapy
- interventionNames
- Procedure: Complete Decongestive Therapy
- type
- OTHER
- label
- Standard of Care for head and neck lymphedema
- description
- Observation
- interventionNames
- Other: Observation
Primary outcomes (1)
- measure
- Change in composite facial measurements
- timeFrame
- During inpatient stay, approximately 3-4 days
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults (18 years of age or older) * Any head and neck cancer patient undergoing laryngectomy, neck dissection, maxillectomy or mandibulectomy * Inpatient and referred for HNL treatment following surgery * Patients with previous chemoradiation therapy or head and neck surgery accepted Exclusion Criteria: * Patients under the age of 18 years of age * Patients who undergo neck dissection surgery that do not present with symptoms of HNL * Patients with free tissue transfer reconstruction * Unwilling or unable to consent
References
Publications (0)
Data not yet available